| 000 | 01765 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517104400.0 | ||
| 264 | 0 | _c20170606 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1525-0024 | ||
| 024 | 7 |
_a10.1038/mt.2016.147 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhitehill, Greg D | |
| 245 | 0 | 0 |
_aAdenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia. _h[electronic resource] |
| 260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _c09 2016 |
||
| 300 |
_a1655-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 |
_aAdenosine _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAntigens, Neoplasm |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity |
| 650 | 0 | 4 |
_aLeukemia _xcomplications |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 |
_aLymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aT-Cell Antigen Receptor Specificity _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 |
_aViruses _ximmunology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAmarnath, Shoba | |
| 700 | 1 | _aMuranski, Pawel | |
| 700 | 1 | _aKeyvanfar, Keyvan | |
| 700 | 1 | _aBattiwalla, Minoo | |
| 700 | 1 | _aBarrett, Austin J | |
| 700 | 1 | _aChinnassamy, Dhanalakshmi | |
| 773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 24 _gno. 9 _gp. 1655-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/mt.2016.147 _zAvailable from publisher's website |
| 999 |
_c26213038 _d26213038 |
||